Compounds > phosphorus
Page last updated: 2024-09-04

phosphorus and canagliflozin

phosphorus has been researched along with canagliflozin in 2 studies

Compound Research Comparison

Studies
(phosphorus)		Trials
(phosphorus)		Recent Studies (post-2010)
(phosphorus)		Studies
(canagliflozin)		Trials
(canagliflozin)		Recent Studies (post-2010) (canagliflozin)
48,0741,12617,139998194975

Protein Interaction Comparison

ProteinTaxonomyphosphorus (IC50)canagliflozin (IC50)
Sodium/glucose cotransporter 1Homo sapiens (human)0.9497
Sodium/glucose cotransporter 2Homo sapiens (human)0.0039

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bauman, V; Bernstein, S; Blau, JE; Collins, MT; Conway, EM; Courville, AB; Piaggi, P; Rother, KI; Taylor, SI; Walter, MF; Wright, EC1
Blau, JE; Taylor, SI1

Trials

1 trial(s) available for phosphorus and canagliflozin

ArticleYear
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study.
    JCI insight, 2018, 04-19, Volume: 3, Issue:8

    Topics: Adult; Canagliflozin; Cross-Over Studies; Diabetes Mellitus, Type 2; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fractures, Bone; Healthy Volunteers; Humans; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Placebos; Sodium-Glucose Transporter 2 Inhibitors; Vitamin D

2018

Other Studies

1 other study(ies) available for phosphorus and canagliflozin

ArticleYear
Adverse effects of SGLT2 inhibitors on bone health.
    Nature reviews. Nephrology, 2018, Volume: 14, Issue:8

    Topics: Bone Demineralization, Pathologic; Bone Density; Canagliflozin; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fractures, Bone; Humans; Parathyroid Hormone; Phosphorus; Sodium-Glucose Transporter 2 Inhibitors; Vitamin D

2018